Proteome Sciences (PRM)

 

PRM Share PerformanceMore

52 week high21.2500 28/04/16
52 week low3.5000 03/03/17
52 week change -16.0000 (-76.19%)
4 week volume9,917,684 02/04/17

Media for (PRM)

Presenter: Christopher Pearce
30/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Proteome Sciences PLC (PRM)

Martin Diggle, Non Executive Director, bought 100,000 shares in the company on the 27th April 2017 at a price of 5.00p. Th...

Director/PDMR Shareholding

RNS Number: 7714D Proteome Sciences PLC 28 April 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 27 April 2017 it purchased 100,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at a pric...

Holding(s) in Company

RNS Number: 7701D Proteome Sciences PLC 28 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PROTEOME SCIENCES PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights...

AGM Statement and Result of AGM

RNS Number: 2782D Proteome Sciences PLC 25 April 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") AGM Statement and Result of AGM At the Company's AGM held today the Chairman, Christopher Pearce, made the following statement: "As stated in our recent results, we expect 2017 to be a transformational year for Proteome Sciences. The c...

Director Dealing and Total Voting Rights

RNS Number: 1111C Proteome Sciences PLC 11 April 2017 Proteome Sciences plc (the "Company" or the "Group") Director Dealing and Total Voting Rights Proteome Sciences plc (AIM:PRM) announces that on 7 April 2017, Ian Pike, Chief Scientific Officer of the Company and a former employee exercised 165,583 and 158,308 options over ordinary shares of 1p each in t...

Holding(s) in Company

RNS Number: 5771B Proteome Sciences PLC 04 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Proteome Sciences plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acqu...

Second Price Monitoring Extn

RNS Number: 5795B Proteome Sciences PLC 04 April 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined p...

Price Monitoring Extension

RNS Number: 5787B Proteome Sciences PLC 04 April 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution...

Fundamental DataMore

EPS-0.96
Dividend yield0 %

Equity Research (PRM)

edison investment research
Proteome Sciences plc
29/01/2015
Edison Investment Research is terminating coverage on Proteome Sciences (PRM). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now...
edison investment research
Proteome Sciences plc
17/11/2014
Proteome Sciences signed its first major biomarker service contract in September. This followed on from the data from the 1,148-patient Alzheimer’s disease (AD) study, which could lead to a blood-...

Latest discussion posts More

  • Would you believe it?

    PRM have done it again! For the second time director buys announced late Friday afternoon: The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") ...
    28-Apr-2017
    The Potter
  • Trading Update

    With reference to the "transformational" expectations and the fear that this is just another CP exaggeration, it's worth pointing out how far CP has exited from the management ...
    26-Apr-2017
    Ctrl-Alt-Delete
  • Re: AGM Trading Update

    B2 - well, not a bad bounce today at all, and the chart isnt looking bad either (YES there is some room for a bit of HOPE!)! Its interesting that the SP found support around ...
    25-Apr-2017
    Andy Reilly

Users' HoldingsMore

Users who hold Proteome Sciences also hold..
LLOYDS GRP.26%
BP18%
BARCLAYS16%
GLAXOSMITHKLINE12%
ROYAL BANK SCOT12%

Codes & Symbols

ISINGB0003104196
SymbolsPRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM